Covista Unveils Strategic Plan for Continued Momentum and Long-Term Value Creation at Investor Day

CHICAGO--(BUSINESS WIRE)--Covista (the "company" or "Covista") (NYSE: ATGE), today will host its Investor Day beginning at 9 a.m. ET. Covista is America's largest healthcare educator, serving more than 97,000 students, up from nearly 76,000 students since its last Investor Day in June 2023, and supported by a community of 385,000 alumni across five accredited institutions. Effective at market open, the company's stock will begin trading under the ticker symbol CVSA on the New York Stock Exchang.

Business Wire • 14 hours ago

Ross University School of Medicine Welcomes New Dean

CHICAGO--(BUSINESS WIRE)--Covista (NYSE: ATGE), America's largest healthcare educator, today announced Cheryl Holmes, M.D., a fellow of the Royal College of Physicians of Canada with a master's degree in health professions education, as the next dean of Ross University School of Medicine (RUSM) effective March 16. “I am thrilled to welcome Dr. Holmes, and confident that her impressive experience spanning clinical practice, research and academic leadership will be invaluable to our students, fac.

Business Wire • Feb 17, 2026

Why Adtalem Global Education (ATGE) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research • Feb 16, 2026

Why This $14 Million Bet on Adtalem Global Stock Could Signal a Healthcare Education Pivot

First Sabrepoint Capital Management initiated a new 135,000-share stake in Adtalem Global Education during the fourth quarter. The quarter-end position value increased by $13.97 million due to the initiation of the new position.

The Motley Fool • Feb 13, 2026

Down 20.9% in 4 Weeks, Here's Why Adtalem (ATGE) Looks Ripe for a Turnaround

Adtalem (ATGE) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Zacks Investment Research • Feb 13, 2026

ATGE or LOPE: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Schools sector might want to consider either Adtalem Global Education (ATGE) or Grand Canyon Education (LOPE). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks Investment Research • Feb 10, 2026

ATGE vs. LOPE: Which Stock Is the Better Value Option?

Investors with an interest in Schools stocks have likely encountered both Adtalem Global Education (ATGE) and Grand Canyon Education (LOPE). But which of these two stocks presents investors with the better value opportunity right now?

Zacks Investment Research • Feb 9, 2026

Adtalem Rebrands as Covista With Focus on Healthcare Workforce Needs

Covista emerges from ATGE's healthcare-focused overhaul, positioning itself as workforce infrastructure aimed at easing America's medical staffing shortage.

Zacks Investment Research • Feb 6, 2026

Are Investors Undervaluing ADTALEM GBL EDU (ATGE) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Research • Feb 5, 2026

Adtalem Global Education Becomes Covista

CHICAGO--(BUSINESS WIRE)--Adtalem Global Education (NYSE: ATGE) today announced it is changing its name to Covista, marking the culmination of a four-year transformation to become America's largest healthcare educator and an essential component of America's healthcare workforce pipeline. The company's stock will begin trading under the ticker symbol CVSA on the New York Stock Exchange on February 24, 2026. "This is not simply a rebrand. It's recognition of what we've built and the problem we ar.

Business Wire • Feb 5, 2026